Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool.

Autor: Priesterbach‐Ackley, L. P.¹ (AUTHOR) Henning.Boldt@rsyd.dk, Boldt, H. B.^2,3 (AUTHOR), Petersen, J. K.^2,3 (AUTHOR), Bervoets, N.¹ (AUTHOR), Scheie, D.⁴ (AUTHOR), Ulhøi, B. P.⁵ (AUTHOR), Gardberg, M.⁶ (AUTHOR), Brännström, T.⁷ (AUTHOR), Torp, S. H.⁸ (AUTHOR), Aronica, E.⁹ (AUTHOR), Küsters, B.¹⁰ (AUTHOR), den Dunnen, W. F. A.¹¹ (AUTHOR), Vos, F. Y. F. L.¹² (AUTHOR), Wesseling, P.^13,14 (AUTHOR), Leng, W. W. J.¹ (AUTHOR), Kristensen, B. W.^2,3 (AUTHOR)

Publikováno v: Neuropathology & Applied Neurobiology. Aug2020, Vol. 46 Issue 5, p478-492. 15p.

Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

Autor: Knudsen, A. M., Eilertsen, I., Kielland, S., Pedersen, M. W., Sorensen, D., Dahlrot, R. H., Boldt, H. B., Mellegaard, C. S., Munthe, S., Poulsen, F. R., Kristensen, B. W.

Publikováno v: Knudsen, A M, Eilertsen, I, Kielland, S, Pedersen, M W, Sorensen, D, Dahlrot, R H, Boldt, H B, Mellegaard, C S, Munthe, S, Poulsen, F R & Kristensen, B W 2018, ' Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas ', Neuro-Oncology, vol. 20, no. Suppl. 3, pp. 284 . https://doi.org/10.1093/neuonc/noy139.259

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::00d92398d82d18aaf3ee0bea61f402b9
https://portal.findresearcher.sdu.dk/da/publications/3e078fdd-ea10-444d-b06d-e4927d467066

P04.41 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

Autor: Knudsen, A M, Eilertsen, I, Kielland, S, Pedersen, M W, Sørensen, M D, Dahlrot, R H, Boldt, H B, Mellegaard, C S, Munthe, S, Poulsen, F R, Kristensen, B W

Publikováno v: Neuro-Oncology. 20:iii288-iii288

BACKGROUND: Gliomas are the most frequent primary brain tumors. For the most malignant glioma - the glioblastoma - the median survival is only 15 months. Few prognostic biomarkers are useful in daily practice, and new markers are urgently needed. EGR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca74d4ecc2ef79aa51dd29e3aa04c814
https://doi.org/10.1093/neuonc/noy139.275

Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin

Autor: Boldt, H. B., Overgaard, M. T., Laursen, L. S., Kathrin Weyer, Sottrup-Jensen, L., Oxvig, C.

Publikováno v: Boldt, H B, Overgaard, M T, Laursen, L S, Weyer, K, Sottrup-Jensen, L, Oxvig, C & Weyer, K 2001, ' Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin ', Biochemical Journal, vol. 358, no. Pt 2, pp. 359-367 .
Aarhus University

The bioavailability of insulin-like growth factor (IGF)-I and -II is controlled by six IGF-binding proteins (IGFBPs 1-6). Bound IGF is not active, but proteolytic cleavage of the binding protein causes release of IGF. Pregnancy-associated plasma prot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::393ccbd8653a19fb91f28ea2240a0610
https://pure.au.dk/portal/da/publications/mutational-analysis-of-the-proteolytic-domain-of-pregnancyassociated-plasma-proteina-pappa-classification-as-a-metzincin(908e8f65-6b64-43c7-9353-6f88ddea2314).html

Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A.

Autor: Laursen LS; Department of Molecular and Structural Biology, University of Aarhus, Science Park, Denmark., Overgaard MT, Søe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C

Publikováno v: FEBS letters [FEBS Lett] 2001 Aug 24; Vol. 504 (1-2), pp. 36-40.